Literature DB >> 20305997

Early Alzheimer's trials: new developments.

B Vellas, P S Aisen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305997     DOI: 10.1007/s12603-010-0064-3

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  9 in total

1.  Dose ranging for trials through biomarkers of drug effects.

Authors:  W Z Potter
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

2.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

3.  Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design.

Authors:  R S Doody
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

4.  Study design considerations: conducting global clinical trials in early Alzheimer's disease.

Authors:  R J Schindler
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

5.  The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.

Authors:  L S Schneider
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

Review 6.  Pre-dementia Alzheimer's trials: overview.

Authors:  P S Aisen
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

7.  Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.

Authors:  J M Cedarbaum; G Crans; M Grundman
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

8.  Clinical trials for early (pre-dementia) Alzheimer's disease: a case for mild cognitive impairment.

Authors:  R C Petersen
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

9.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

  9 in total
  4 in total

Review 1.  Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.

Authors:  Cédric Annweiler; Olivier Beauchet
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 2.  Brain investigation and brain conceptualization.

Authors:  Alberto Redolfi; Paolo Bosco; David Manset; Giovanni B Frisoni
Journal:  Funct Neurol       Date:  2013 Jul-Sep

3.  Advances in tau-based drug discovery.

Authors:  Wendy Noble; Amy M Pooler; Diane P Hanger
Journal:  Expert Opin Drug Discov       Date:  2011-08-01       Impact factor: 6.098

4.  Vitamin D supplements: a novel therapeutic approach for Alzheimer patients.

Authors:  Cedric Annweiler; Spyridon N Karras; Panagiotis Anagnostis; Olivier Beauchet
Journal:  Front Pharmacol       Date:  2014-01-28       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.